PND32 EVALUATION OF GLOBAL IMPROVEMENT AND LIFETIME COSTS OF TREATING TARDIVE DYSKINESIA SHOWS TREATMENT WITH VALBENAZINE DOMINATES DEUTETRABENAZINE
May 1, 2019, 00:00
10.1016/j.jval.2019.04.1305
https://www.valueinhealthjournal.com/article/S1098-3015(19)31497-4/fulltext
Title :
PND32 EVALUATION OF GLOBAL IMPROVEMENT AND LIFETIME COSTS OF TREATING TARDIVE DYSKINESIA SHOWS TREATMENT WITH VALBENAZINE DOMINATES DEUTETRABENAZINE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)31497-4&doi=10.1016/j.jval.2019.04.1305
First page :
Section Title :
Open access? :
No
Section Order :
10804